Inter-Brain Synchrony in Psychotherapy for Depression
NCT06196346 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2024-12-10
Summary
The study aims to examine inter-brain synchrony between patients and therapists over the course of psychotherapy. Twenty patients will undergo a 16-session course of psychotherapy for major depressive disorder. The protocol used will be supportive-expressive psychotherapy (see Luborsky et al., 1995). Participants will also undergo Hamilton depression interviews a week before treatment, before every session and a week after treatment. functional near-infrared spectroscopy (fNIRS) imaging will be used to record brain activity during every other session (sessions 1, 3, 5, 7, 9, 11, 13, 15) as well as during interviews at baseline, on session 8 and at followup. Saliva samples will be collected during the same sessions to measure hormone and cytokine levels during the same sessions. Participants completed questionnaires before and after the study, and before and after each session.
The researchers hypothesized that synchrony will gradually increase over the psychotherapy sessions, and that synchrony in the pre-treatment interview will be lower than in the post-treatment interview.
Conditions
Interventions
- BEHAVIORAL
-
Psychotherapy
see group description
Sponsors & Collaborators
-
Society for the Advancement of Psychotherapy
collaborator UNKNOWN -
University of Haifa
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-23
- Primary Completion
- 2024-09-19
- Completion
- 2024-09-19
Countries
- Israel
Study Locations
More Related Trials
-
Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
NCT00641108 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ketamine and Nitroprusside for Depression
NCT03102736 ·Status: COMPLETED ·Phase: PHASE2
-
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
NCT06592833 ·Status: RECRUITING ·Phase: PHASE2
-
Interpersonal Psychotherapy for Severely Depressed Inpatients
NCT00325000 ·Status: TERMINATED ·Phase: NA
-
Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression
NCT00928980 ·Status: COMPLETED ·Phase: NA
-
Intensive Accelerated iTBS for the Treatment-Resistant Depression
NCT06166082 ·Status: COMPLETED ·Phase: NA
-
The Nocebo Effect: a Prospective Study of Informed Consent as a Factor in the Prevalence of SSRI's Side Effects
NCT01200615 ·Status: UNKNOWN ·Phase: NA
-
Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study
NCT05950711 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
NCT01903447 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Postpartum Depression With Psychotherapy and Add-on Sertraline
NCT01028482 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach
NCT06306209 ·Status: RECRUITING
-
Discontinuation of Antidepressant Medication in Primary Care.
NCT03361514 ·Status: COMPLETED ·Phase: NA
-
The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder
NCT01418638 ·Status: UNKNOWN
-
Wellbutrin XL Effects on SSRIs Induced Changes
NCT00456820 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Post-Traumatic Brain Injury (TBI) Depression
NCT00233103 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder
NCT05385783 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
NCT00953745 ·Status: COMPLETED ·Phase: NA
-
Sertraline vs. Placebo for Symptoms Following Traumatic Brain Injury
NCT00208585 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
NCT00781326 ·Status: TERMINATED ·Phase: PHASE4
-
Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
NCT00232167 ·Status: TERMINATED ·Phase: PHASE3
-
PET Whole Body Distribution Studies Using [11C]CUMI
NCT01132872 ·Status: COMPLETED
-
Treatment of Mild and Subthreshold Depressive Disorders
NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
NCT00705003 ·Status: COMPLETED ·Phase: PHASE2
-
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
NCT00794040 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Therapy for Recurrent Depression
NCT00118404 ·Status: COMPLETED ·Phase: PHASE3